Literature DB >> 8714231

Environmental risk factors in inflammatory bowel disease.

I Koutroubakis1, O N Manousos, S G Meuwissen, A S Pena.   

Abstract

Besides a genetic predisposition, a causal role of various environmental factors have been taken into consideration in the etiology of inflammatory bowel disease (IBD). The most consistent association of environmental factors so far identified is the association between non smoking and ulcerative colitis (UC) as well a between smoking and Crohn's disease (CD). Other factors such as oral contraceptives, refined sugar, perinatal events, childhood infections, microbial agents, and domestic hygiene have been found to be associated with ulcerative colitis and Crohn's disease but further evaluation is required to confirm the consistency and to define the strength of the association. Recent data also suggest that measles virus may persist in intestinal tissue and early exposure to the virus may be a risk factor for development of CD. The further investigation of environmental factors on IBD and the explanation of their role is expected to open new avenues for basic scientific research and may lead to the development of a more rational approach to the prevention and treatment of IBD. The available data suggest that UC and CD are heterogeneous disorders of multifactorial etiology in which hereditary and environmental factors interact to produce the disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8714231

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  15 in total

Review 1.  The CD40/CD40L costimulatory pathway in inflammatory bowel disease.

Authors:  S Danese; M Sans; C Fiocchi
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

2.  Autoantibodies pANCA, GAB and PAB in inflammatory bowel disease: prevalence, characteristics and diagnostic value.

Authors:  Evgenija Homsak; Dusanka Micetić-Turk; Borut Bozic
Journal:  Wien Klin Wochenschr       Date:  2010-05       Impact factor: 1.704

3.  A meta-analysis of antibiotic therapy for active ulcerative colitis.

Authors:  Roja Rahimi; Shekoufeh Nikfar; Ali Rezaie; Mohammad Abdollahi
Journal:  Dig Dis Sci       Date:  2007-04-06       Impact factor: 3.199

4.  Association of inflammatory bowel disease with indicators for childhood antigen and infection exposure.

Authors:  Jochen Hampe; Kerstin Heymann; Michael Krawczak; Stefan Schreiber
Journal:  Int J Colorectal Dis       Date:  2003-04-10       Impact factor: 2.571

5.  Haplotype of prostaglandin synthase 2/cyclooxygenase 2 is involved in the susceptibility to inflammatory bowel disease.

Authors:  David-G Cox; J-Bart-A Crusius; Petra-H-M Peeters; H-Bas Bueno-de-Mesquita; A-Salvador Pena; Federico Canzian
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

6.  Budesonide Loaded PLGA Nanoparticles for Targeting the Inflamed Intestinal Mucosa--Pharmaceutical Characterization and Fluorescence Imaging.

Authors:  Hussain Ali; Benno Weigmann; Eva-Maria Collnot; Saeed Ahmad Khan; Maike Windbergs; Claus-Michael Lehr
Journal:  Pharm Res       Date:  2015-12-30       Impact factor: 4.200

7.  A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort.

Authors:  J Hampe; S Schreiber; S H Shaw; K F Lau; S Bridger; A J Macpherson; L R Cardon; H Sakul; T J Harris; A Buckler; J Hall; P Stokkers; S J van Deventer; P Nürnberg; M M Mirza; J C Lee; J E Lennard-Jones; C G Mathew; M E Curran
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

8.  Cytokine-induced alterations of α7 nicotinic receptor in colonic CD4 T cells mediate dichotomous response to nicotine in murine models of Th1/Th17- versus Th2-mediated colitis.

Authors:  Valentin Galitovskiy; Jing Qian; Alexander I Chernyavsky; Steve Marchenko; Vivian Gindi; Robert A Edwards; Sergei A Grando
Journal:  J Immunol       Date:  2011-07-22       Impact factor: 5.422

Review 9.  Pulmonary involvement and allergic disorders in inflammatory bowel disease.

Authors:  Nikolaos E Tzanakis; Ioanna G Tsiligianni; Nikolaos M Siafakas
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

Review 10.  Hematological malignancies in chronic inflammatory bowel diseases: report of five cases and review of the literature.

Authors:  Pietro Crispino; Roberta Pica; Erika Angelucci; Adriana Consolazio; Margherita Rivera; Claudio Cassieri; Paolo Paoluzi
Journal:  Int J Colorectal Dis       Date:  2006-10-07       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.